// App-Quantinova.ai

AB0623 (2022) : A review of the evidence behind the recommendation of rituximab for ANCA associated vasculitis

Researchers

Presenter

  • H. Amin

Principal Investigators

  • M. Bukhari

Medical Centers

  • Lancaster Medical School, faculty of health and medicine, Bailrigg, United Kingdom

  • University Hospitals of Morecambe Bay NHS Foundation Trust, Rheumatology, royal lancaster infirmary, lancaster, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Autoimmune (AI)

Disease

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved